<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-19T02:14:11Z</responseDate><request verb="GetRecord" identifier="oai:repository.ajou.ac.kr:201003/1433" metadataPrefix="oai_dc">https://repository.ajou.ac.kr/oai/request</request><GetRecord><record><header><identifier>oai:repository.ajou.ac.kr:201003/1433</identifier><datestamp>2024-10-11T02:17:30Z</datestamp><setSpec>com_201003_14369</setSpec><setSpec>com_201003_14368</setSpec><setSpec>col_201003_14371</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Roles of Interferon Lambda on Hepatitis B Virus Replication</dc:title>
<dc:title>B형 간염 바이러스의 감염과 관련된 인터페론 람다 시스템의 역할과 조절</dc:title>
<dc:creator>홍, 승호</dc:creator>
<dc:contributor>박, 선</dc:contributor>
<dc:contributor>대학원 의학과</dc:contributor>
<dc:contributor>104772</dc:contributor>
<dc:contributor>홍, 승호</dc:contributor>
<dc:subject>Hepatitis B Virus</dc:subject>
<dc:subject>IFN-lambda-1 protein</dc:subject>
<dc:subject>Virus replications</dc:subject>
<dc:description>"Background/Aims: Chronic hepatitis B virus (HBV) infection is a major cause of liver disease. Only interferon-α (IFN-α) and the nucleosidic inhibitors of the viral polymerase, lamivudine and adefovir, are approved for therapy. However, these therapies are limited by the side effects of interferon and by the substantial resistance of the virus to nucleosidic inhibitors. New antiviral molecules suitable for monotherapy or combination therapy are highly desired. Recently described IFN-λ family utilizing its distinct cellular receptor has been reported to exert inhibitory effect on replication of several viruses. In this study, I wanted to know whether IFN-λ1 inhibits HBV replication in human hepatoma cell lines and whether HBV modulates expression of CRF2-12, a subunit of IFN-λ1 receptor. In addition, I wanted to establish ELISA for IFN-λ1 to examine HBV mediated modulation of IFN-λ1 production.

Methods: I produced IFN-λ1 using E.coli expression system. For antiviral activity of IFN-λ1, I used a functional form of MBP-IFN-λ1 and for generation of antibody against IFN-λ1, I used His-IFN-λ1. I analyzed HBV replication in WT10 and PEB8 human hepatoma cell lines supporting HBV replication, after treatment of these cells with IFN-λ1 by real-time PCR and Southern blotting. After treatment of PEB8 with IFN-λ1, I examined the transcription level of HBV by Northern blotting and the amount of secretory viral Ag by ELISA. I performed the RT-PCR to investigate the induction of antiviral proteins, MxA and 2’5’-OAS, by IFN-λ1. I investigated the expression of CRF2-12 by RT-PCR and Western blotting. I generated monoclonal Abs against IFN-λ1 using splenocytes from immunized mice and determined the detection limit of ELISA using these Abs.

Results: HBV replication in PEB8 but not in WT10 was suppressed by IFN-λ1 treatment. In both cell lines, similar amount of CRF2-12 to that in their parental cell line was expressed, and similar amount of transcripts of MxA as well as 2’5’-OAS were induced by IFN-λ1. In PEB8, neither HBV transcripts nor secretory Ag was affected by IFN-λ1 treatment. IFN-λ1 was detected by ELISA using monoclonal Abs and polyclonal Ab generated in this study with the detection limit of 40 ng/ml.

Conclusions: Antiviral activity of IFN-λ1 on HBV was demonstrated in one of two human hepatoma cell lines suggesting that the effect of IFN-λ1 may be dependent on the cellular factors, and/or viral factors. My results showed that CRF2-12 expression was not regulated by HBV replication. Finally, an assay for IFN-λ1 production was established.

"</dc:description>
<dc:description>"ABSTRACT 	 i

TABLE OF CONTENTS 	 iii

LIST OF FIGURES 	 vi

LIST OF TABLES 	 vii

ABBREVIATION 	 viii

I.	INTRODUCTION 	 1

A.	Background 	 1

1.	Hepatitis B virus 	 1

2.	Interferon alpha 	 5

3.	Interferon lambda 	 8

B.	Aims 	 12

II.	MATERIALS AND METHODS 	 13

A.	Expression vectors for IFN-λ1 and its receptor subunit CRF2-12 	 13

B.	Purification of the recombinant proteins 	 14

1.	Expression and purification of MBP-IFN-λ1 in E. coli 	 14

2.	Expression and purification of His-IFN-λ1 and His-CRF2-12 

in E. coli 	 16

3.	Expression and purification of CRF2-12-mIg in COSM6 	 17

C.	SDS-PAGE 	 17

D.	Western blotting 	 17

E.	RNA preparation 	 19

F.	Reverse transcription-polymerase chain reaction 	 19

G.	Isolation of HBV core DNA 	 22

H.	Real-time PCR 	 23

I.	Southern blotting 	 24

J.	Northern blotting 	 24

K.	Enzyme-linked immunosorbent assay 	 25

1.	Secretion of HBsAg and HBeAg 	 25

2.	Screening of monoclonal anti-IFN-λ1 Ab 	 25

3.	Sensitivity of anti-IFN-λ1 Abs against IFN-λ1 	 25

L.	Cell fusion	 26

M.	Limiting dilution 	 27

N.	Isotyping of monoclonal Abs 	 28

O.	Large production of monoclonal anti-IFN-λ1 Ab 	 28

P.	The production of polyclonal anti-IFN-λ1 Ab and anti-CRF2-12 Ab 	 29

III.	RESULTS 	 30

A.	Expression and purification of IFN-λ1 	 30

B.	Functional activity of IFN-λ1 	 32

C.	Expression of CRF2-12 in HBV replicating human hepatoma cell lines

    	 34

D.	Induction of antiviral transcripts in HBV replicating human hepatoma 

cell lines by IFN-λ1	 38

E.	The effect of IFN-λ1 on HBV replication 	 40

F.	The effect of IFN-λ1 on HBV transcription 	 43

G.	The effect of IFN-λ1 on the secretion of HBsAg and HBeAg 	 43

H.	Generation of the polyclonal and the monoclonal Abs against IFN-λ1 	 46

I.	Establishment of ELISA for IFN-λ1 	 48

IV.	DISCUSSION 	 50

V.	CONCLUSION 	 54

REFERENCES 	 56

국문요약	 64

"</dc:description>
<dc:description>Doctor</dc:description>
<dc:date>2011-02-08T05:40:59Z</dc:date>
<dc:date>2011-02-08T05:40:59Z</dc:date>
<dc:date>2006</dc:date>
<dc:date>2006</dc:date>
<dc:type>Thesis</dc:type>
<dc:type>Theses</dc:type>
<dc:identifier>http://repository.ajou.ac.kr/handle/201003/1433</dc:identifier>
<dc:identifier>http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000001230</dc:identifier>
<dc:identifier>000000001230</dc:identifier>
<dc:language>en</dc:language>
</oai_dc:dc>
</metadata></record></GetRecord></OAI-PMH>